Scholarly Index
Laurence Collette
GlaxoSmithKline (Belgium); 49,603 total citations; 418 total publications; best world rank #104
GlaxoSmithKline (Belgium)
49,603Total citations
418Total publications
99H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Prostate Cancer Treatment and Research | Lifetime | 162 | BE 3 | 99.44 |
| Prostate Cancer Diagnosis and Treatment | Lifetime | 232 | BE 4 | 99.23 |
| Testicular diseases and treatments | Lifetime | 104 | BE 2 | 98.52 |
| Colorectal Cancer Surgical Treatments | Lifetime | 405 | BE 6 | 98.09 |
| Colorectal and Anal Carcinomas | Lifetime | 319 | BE 3 | 97.89 |
| Cancer Diagnosis and Treatment | Lifetime | 843 | BE 6 | 96.25 |
| Bladder and Urothelial Cancer Treatments | Lifetime | 741 | BE 3 | 97.30 |
| Statistical Methods in Clinical Trials | Lifetime | 295 | BE 5 | 96.30 |
| Advances in Oncology and Radiotherapy | Lifetime | 639 | BE 11 | 90.45 |
| Testicular diseases and treatments | 2021-2025 | 657 | BE 9 | 66.69 |